相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Downregulation of miR-130b∼301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
Joao Ramalho-Carvalho et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes
Keiko Mizuno et al.
JOURNAL OF HUMAN GENETICS (2017)
MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
Jorge Torres-Ferreira et al.
MOLECULAR CANCER (2017)
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1
Joao Ramalho-Carvalho et al.
CANCER LETTERS (2017)
MicroRNA-375 plays a dual role in prostate carcinogenesis
Pedro Costa-Pinheiro et al.
CLINICAL EPIGENETICS (2015)
The first case of human autochtonous subconjunctival dirofilariosis in Poland and MALT lymphoma as possible consequence of this parasitosis
Piotr K. Borkowski et al.
INFECTIOUS AGENTS AND CANCER (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
Alvaro Aytes et al.
CANCER CELL (2014)
c-MYC-miRNA circuitry A central regulator of aggressive B-cell malignancies
Jiangchuan Tao et al.
CELL CYCLE (2014)
MiR-23a Functions as a Tumor Suppressor in Osteosarcoma
Yu He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
Donald J. Vander Griend et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Prostate cancer: the need for biomarkers and new therapeutic targets
Juliana Felgueiras et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Rhonda L. Bitting et al.
ENDOCRINE-RELATED CANCER (2013)
8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy
Gaelle Fromont et al.
HUMAN PATHOLOGY (2013)
c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2
Xiaoni Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer
Marina Frana de Resende et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Lina Gao et al.
PLOS ONE (2013)
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
Eva van Rooij et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
Al B. Barqawi et al.
ADVANCES IN UROLOGY (2012)
Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
Volkhard Seitz et al.
PLOS ONE (2011)
Epigenetics and the Environmental Regulation of the Genome and Its Function
Tie-Yuan Zhang et al.
ANNUAL REVIEW OF PSYCHOLOGY (2010)
Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer
Joao R. Carvalho et al.
APOPTOSIS (2010)
Molecular genetics of prostate cancer: new prospects for old challenges
Michael M. Shen et al.
GENES & DEVELOPMENT (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC Expression
Mark M. Pomerantz et al.
CANCER RESEARCH (2009)
How epigenetics can explain human metastasis A new role for microRNAs
Amaia Lujambio et al.
CELL CYCLE (2009)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors
Yoh Dobashi et al.
MODERN PATHOLOGY (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
William M. Merritt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Integration of genome and chromatin structure with gene expression profiles to predict c-MYC recognition site binding and function
Yili Chen et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes
Kevin C. Miranda et al.
CELL (2006)
8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects
Franclim R. Ribeiro et al.
CLINICAL CANCER RESEARCH (2006)
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
Michael D. Mattie et al.
MOLECULAR CANCER (2006)
ROCR: visualizing classifier performance in R
T Sing et al.
BIOINFORMATICS (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma
WA Schulz et al.
GENES CHROMOSOMES & CANCER (2002)